Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience

Korkmaz, ONUR; CAGLAN, Figen; AYKIN, Nevil; NAZ, Hasan; TOKA, ONUR

doi:10.4274/vhd.94830

Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience

Copy For Citation

Korkmaz P., CAGLAN F. C., AYKIN N., NAZ H., TOKA O.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.22, no.3, pp.92-96, 2016 (ESCI)

Publication Type: Article / Article
Volume: 22 Issue: 3
Publication Date: 2016
Doi Number: 10.4274/vhd.94830
Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Page Numbers: pp.92-96
Hacettepe University Affiliated: Yes

Abstract

Objective: The aim of the study was to evaluate the long-term results of treatment efficacy and safety in nucleos(t)ide analogue-naive (NA-naive) and NA-experienced chronic hepatitis B (CHB) patients receiving tenofovir disoproxil fumarate (TDF) therapy.